While they found that higher BMI was independently associated with worse survival in women with early HER2+ BC (5099 patients), they unexpectedly found that higher BMI was independently associated with better survival in women with advanced HER2+ BC (3496 patients) [55]. Here, ERBB2 is linked to breast cancer.